H3K9 acetylation modification and TLR9 immune regulation mechanism in patients after anti-HBV treatment

To improve the curative effect of anti-hepatitis B virus (HBV) drugs, methods such as thymosin and entecavir combination have become a focus of clinical investigation. The aim of this retrospective experimental study was to explore the potential mechanism of action of thymosin a1 (Ta1) combined with...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Haipeng, Wang, Ke, Du, Wei, Cao, Huanhuan, Zhong, Qingyang, Yin, Sichun, Zhong, Jianbo, Li, Fawu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
4500
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9803445/
https://www.ncbi.nlm.nih.gov/pubmed/36596032
http://dx.doi.org/10.1097/MD.0000000000032431

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9803445/
https://www.ncbi.nlm.nih.gov/pubmed/36596032
http://dx.doi.org/10.1097/MD.0000000000032431

Ejemplares similares